Profiel
Michal Segal-Salto is currently the Chief Human Resources Officer & Senior VP at Delta Galil Industries Ltd. and also holds the position of Vice President-Human Resources at IDE Technologies Ltd. Previously, Michal worked as the Vice President-Research & Development at Chemomab Therapeutics Ltd. from 2015 to 2022.
Michal has a doctorate degree from the Weizmann Institute of Science and completed undergraduate and graduate studies at The Hebrew University of Jerusalem.
Actieve functies van Michal Segal-Salto
| Bedrijven | Functie | Begin |
|---|---|---|
| DELTA GALIL INDUSTRIES LTD. | Human Resources Officer | 01-01-2023 |
IDE Technologies Ltd.
IDE Technologies Ltd. Industrial MachineryProducer Manufacturing Designs, manufactures and installs water desalination equipment | Human Resources Officer | - |
Eerdere bekende functies van Michal Segal-Salto
| Bedrijven | Functie | Einde |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Hoofd Techniek/Wetenschap/O&O | 12-08-2022 |
Opleiding van Michal Segal-Salto
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Delta Galil Industries Ltd.
Delta Galil Industries Ltd. Apparel/FootwearConsumer Non-Durables Manufactures and markets undergarments and intimate apparel | Consumer Non-Durables |
IDE Technologies Ltd.
IDE Technologies Ltd. Industrial MachineryProducer Manufacturing Designs, manufactures and installs water desalination equipment | Producer Manufacturing |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
















